Blackstone to Pay $750 Million to Fund J&J Drug Development
Blackstone will pay $750 million to fund Phase 3 development of OLN324.
Story updates
01:06:11 PM UTC
SquawkNews
Johnson & Johnson: Blackstone to Pay $750 Million Over Multiple Years to Fully Fund Phase 3 Development of OLN324 >JNJ